Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo Miguel Mendivil-PerezMarlene Jimenez-Del-RioCarlos Velez-Pardo Original Paper 17 May 2022 Article: 109
Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment Peipei YangJie DingJuan Li Review Article 17 May 2022 Article: 108
Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management Alfredo TartaroneRosa LeroseMarina Tartarone Review Article 13 May 2022 Article: 107
Alterations in cellular metabolisms after Imatinib therapy: a review Veerandra KumarPriyanka SinghMalkhey Verma Review Article 16 May 2022 Article: 95
Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway Chi LiuShan JiangXiaoguang Yu Original Paper 16 May 2022 Article: 94
Engineering tumor-derived small extra cellular vesicles to encapsulate miR-34a, effectively inhibits 4T1 cell proliferation, migration, and gene expression Mahsa HajivaliliKaveh BaghaeiDavar Amani Original Paper 15 May 2022 Article: 93
Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape Lingli HuangXin LiuZhixian Liu Original Paper 15 May 2022 Article: 92
The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications Seyed Hossein ShahcheraghiFateme SalemiMarzieh Lotfi Review Article 15 May 2022 Article: 91
TMCO1 expression promotes cell proliferation and induces epithelial–mesenchymal transformation in human gliomas Lun GaoZhang YeQian-Xue Chen Original Paper 15 May 2022 Article: 90
Cell line models for drug discovery in PIK3CA-mutated colorectal cancers Ioannis A. Voutsadakis Original Paper 15 May 2022 Article: 89
Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro Xiaoyu YangYan WangMorteza Akbari Original Paper 18 May 2022 Article: 88
The role of histone deacetylase 3 in breast cancer Rezgar RahbariYousef RasmiMohammad Abdi Review Article 17 May 2022 Article: 84
Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway Zhuo ChenJing WuJie He Original Paper 16 May 2022 Article: 83
PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer Sutapa MahataPranab K. SahooVilas D. Nasare Review Article 15 May 2022 Article: 74
Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations Azmi Yerlikaya Review Article 15 May 2022 Article: 73
The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma Hui HuangTao ChenJiehui Di Review Article 15 May 2022 Article: 72
A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression Nicole E. JamesMegan GuraJennifer R. Ribeiro Original Paper 15 May 2022 Article: 71
20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cells Wenmo LiuSiqi WangXianghui Yu Original Paper 15 May 2022 Article: 70
